HER2 IHC Score as a Predictor of Pathologic Complete Response in HER2-Positive Breast Cancer After Neoadjuvant Therapy
Aim: This study aims to evaluate the factors associated with pathologic complete response (pCR) in human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients receiving neoadjuvant therapy, with a specific focus on the prognostic relevance of HER2 immunohistochemistry (IHC) scores. Methods: This ret...